Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone

L. Heartsill, M. L. Richards, N. Arfai, A. Lee, J. Bingener-Casey, W. H. Schwesinger, K. R. Sirinek

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: The Rives-Stoppa (RS) repair of ventral incisional hernias (VIHR) is technically difficult. It involves the retromuscular placement of mesh anterior to the posterior fascia and the primary closure of the anterior fascia. Recurrence rates are 0-8%. We proposed that the operation could be done with equal success by placing the mesh in an intraperitoneal position and primarily closing the fascia anterior to the mesh. Methods: 81 patients who had undergone an open RS-VIHR with intraperitoneal mesh were evaluated for hernia recurrence and factors associated with recurrence. Results: 55 women and 26 men (mean BMI 38±9) underwent RS-VIHR (mean age 49±11 years). Of these patients, 44 (54%) had a prior VIHR, 30 (37%) had an incarcerated hernia and 34 (42%) had multiple fascial defects. PTFE was used in 83% and Prolene in 12%. Average LOS was 5.8±12 days. All received perioperative intravenous antibiotics and 28% were discharged on oral antibiotics. Follow-up averaged 30±24 months. Recurrent VIH developed in 12/81 (15%), with three occurring after removal of infected mesh and one after a laparotomy. Excluding these four, the recurrence rate was 10%. There was no correlation between hernia recurrence and age, BMI, hernia size, number of prior repairs, or LOS (t- test p >0.05). Hernia recurrence did not correlate with gender, prior peritoneal contamination, incarceration, multiple defects, adhesions, mesh type, oral antibiotics, cardiac disease, diabetes, tobacco use, or seroma (X2 p>0.05). Those with a wound infection and/or abscess formation had a significantly higher recurrent hernia rate (60% vs. 8%, X2 p<0.001). Patients with pulmonary disease had a significantly higher recurrence rate (50% vs. 12%, X2 p=0.01). Conclusions: RS-VIHR with intraperitoneal mesh is a successful and less technically challenging method of repair than prior modifications. Aggressive efforts to identify infection and treat early may prevent abscess formation and subsequent recurrent hernia. Patients with chronic pulmonary disease have an unacceptably high recurrence rate and should not be considered as candidates for elective RS-VIHR.

Original languageEnglish (US)
Pages (from-to)162-166
Number of pages5
JournalHernia
Volume9
Issue number2
DOIs
StatePublished - May 2005
Externally publishedYes

Fingerprint

Ventral Hernia
Herniorrhaphy
Hernia
Recurrence
Fascia
Anti-Bacterial Agents
Abscess
Lung Diseases
Seroma
Polypropylenes
Polytetrafluoroethylene
Tobacco Use
Wound Infection
Laparotomy
Incisional Hernia
Heart Diseases
Chronic Disease

Keywords

  • Prosthetic mesh
  • Rives-Stoppa
  • Ventral hernia repair

ASJC Scopus subject areas

  • Surgery

Cite this

Heartsill, L., Richards, M. L., Arfai, N., Lee, A., Bingener-Casey, J., Schwesinger, W. H., & Sirinek, K. R. (2005). Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone. Hernia, 9(2), 162-166. https://doi.org/10.1007/s10029-005-0319-9

Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone. / Heartsill, L.; Richards, M. L.; Arfai, N.; Lee, A.; Bingener-Casey, J.; Schwesinger, W. H.; Sirinek, K. R.

In: Hernia, Vol. 9, No. 2, 05.2005, p. 162-166.

Research output: Contribution to journalArticle

Heartsill, L, Richards, ML, Arfai, N, Lee, A, Bingener-Casey, J, Schwesinger, WH & Sirinek, KR 2005, 'Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone', Hernia, vol. 9, no. 2, pp. 162-166. https://doi.org/10.1007/s10029-005-0319-9
Heartsill L, Richards ML, Arfai N, Lee A, Bingener-Casey J, Schwesinger WH et al. Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone. Hernia. 2005 May;9(2):162-166. https://doi.org/10.1007/s10029-005-0319-9
Heartsill, L. ; Richards, M. L. ; Arfai, N. ; Lee, A. ; Bingener-Casey, J. ; Schwesinger, W. H. ; Sirinek, K. R. / Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone. In: Hernia. 2005 ; Vol. 9, No. 2. pp. 162-166.
@article{f49ad13fa3d140b7a38f06a487836d89,
title = "Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone",
abstract = "Background: The Rives-Stoppa (RS) repair of ventral incisional hernias (VIHR) is technically difficult. It involves the retromuscular placement of mesh anterior to the posterior fascia and the primary closure of the anterior fascia. Recurrence rates are 0-8{\%}. We proposed that the operation could be done with equal success by placing the mesh in an intraperitoneal position and primarily closing the fascia anterior to the mesh. Methods: 81 patients who had undergone an open RS-VIHR with intraperitoneal mesh were evaluated for hernia recurrence and factors associated with recurrence. Results: 55 women and 26 men (mean BMI 38±9) underwent RS-VIHR (mean age 49±11 years). Of these patients, 44 (54{\%}) had a prior VIHR, 30 (37{\%}) had an incarcerated hernia and 34 (42{\%}) had multiple fascial defects. PTFE was used in 83{\%} and Prolene in 12{\%}. Average LOS was 5.8±12 days. All received perioperative intravenous antibiotics and 28{\%} were discharged on oral antibiotics. Follow-up averaged 30±24 months. Recurrent VIH developed in 12/81 (15{\%}), with three occurring after removal of infected mesh and one after a laparotomy. Excluding these four, the recurrence rate was 10{\%}. There was no correlation between hernia recurrence and age, BMI, hernia size, number of prior repairs, or LOS (t- test p >0.05). Hernia recurrence did not correlate with gender, prior peritoneal contamination, incarceration, multiple defects, adhesions, mesh type, oral antibiotics, cardiac disease, diabetes, tobacco use, or seroma (X2 p>0.05). Those with a wound infection and/or abscess formation had a significantly higher recurrent hernia rate (60{\%} vs. 8{\%}, X2 p<0.001). Patients with pulmonary disease had a significantly higher recurrence rate (50{\%} vs. 12{\%}, X2 p=0.01). Conclusions: RS-VIHR with intraperitoneal mesh is a successful and less technically challenging method of repair than prior modifications. Aggressive efforts to identify infection and treat early may prevent abscess formation and subsequent recurrent hernia. Patients with chronic pulmonary disease have an unacceptably high recurrence rate and should not be considered as candidates for elective RS-VIHR.",
keywords = "Prosthetic mesh, Rives-Stoppa, Ventral hernia repair",
author = "L. Heartsill and Richards, {M. L.} and N. Arfai and A. Lee and J. Bingener-Casey and Schwesinger, {W. H.} and Sirinek, {K. R.}",
year = "2005",
month = "5",
doi = "10.1007/s10029-005-0319-9",
language = "English (US)",
volume = "9",
pages = "162--166",
journal = "Hernia : the journal of hernias and abdominal wall surgery",
issn = "1265-4906",
publisher = "Springer Paris",
number = "2",

}

TY - JOUR

T1 - Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone

AU - Heartsill, L.

AU - Richards, M. L.

AU - Arfai, N.

AU - Lee, A.

AU - Bingener-Casey, J.

AU - Schwesinger, W. H.

AU - Sirinek, K. R.

PY - 2005/5

Y1 - 2005/5

N2 - Background: The Rives-Stoppa (RS) repair of ventral incisional hernias (VIHR) is technically difficult. It involves the retromuscular placement of mesh anterior to the posterior fascia and the primary closure of the anterior fascia. Recurrence rates are 0-8%. We proposed that the operation could be done with equal success by placing the mesh in an intraperitoneal position and primarily closing the fascia anterior to the mesh. Methods: 81 patients who had undergone an open RS-VIHR with intraperitoneal mesh were evaluated for hernia recurrence and factors associated with recurrence. Results: 55 women and 26 men (mean BMI 38±9) underwent RS-VIHR (mean age 49±11 years). Of these patients, 44 (54%) had a prior VIHR, 30 (37%) had an incarcerated hernia and 34 (42%) had multiple fascial defects. PTFE was used in 83% and Prolene in 12%. Average LOS was 5.8±12 days. All received perioperative intravenous antibiotics and 28% were discharged on oral antibiotics. Follow-up averaged 30±24 months. Recurrent VIH developed in 12/81 (15%), with three occurring after removal of infected mesh and one after a laparotomy. Excluding these four, the recurrence rate was 10%. There was no correlation between hernia recurrence and age, BMI, hernia size, number of prior repairs, or LOS (t- test p >0.05). Hernia recurrence did not correlate with gender, prior peritoneal contamination, incarceration, multiple defects, adhesions, mesh type, oral antibiotics, cardiac disease, diabetes, tobacco use, or seroma (X2 p>0.05). Those with a wound infection and/or abscess formation had a significantly higher recurrent hernia rate (60% vs. 8%, X2 p<0.001). Patients with pulmonary disease had a significantly higher recurrence rate (50% vs. 12%, X2 p=0.01). Conclusions: RS-VIHR with intraperitoneal mesh is a successful and less technically challenging method of repair than prior modifications. Aggressive efforts to identify infection and treat early may prevent abscess formation and subsequent recurrent hernia. Patients with chronic pulmonary disease have an unacceptably high recurrence rate and should not be considered as candidates for elective RS-VIHR.

AB - Background: The Rives-Stoppa (RS) repair of ventral incisional hernias (VIHR) is technically difficult. It involves the retromuscular placement of mesh anterior to the posterior fascia and the primary closure of the anterior fascia. Recurrence rates are 0-8%. We proposed that the operation could be done with equal success by placing the mesh in an intraperitoneal position and primarily closing the fascia anterior to the mesh. Methods: 81 patients who had undergone an open RS-VIHR with intraperitoneal mesh were evaluated for hernia recurrence and factors associated with recurrence. Results: 55 women and 26 men (mean BMI 38±9) underwent RS-VIHR (mean age 49±11 years). Of these patients, 44 (54%) had a prior VIHR, 30 (37%) had an incarcerated hernia and 34 (42%) had multiple fascial defects. PTFE was used in 83% and Prolene in 12%. Average LOS was 5.8±12 days. All received perioperative intravenous antibiotics and 28% were discharged on oral antibiotics. Follow-up averaged 30±24 months. Recurrent VIH developed in 12/81 (15%), with three occurring after removal of infected mesh and one after a laparotomy. Excluding these four, the recurrence rate was 10%. There was no correlation between hernia recurrence and age, BMI, hernia size, number of prior repairs, or LOS (t- test p >0.05). Hernia recurrence did not correlate with gender, prior peritoneal contamination, incarceration, multiple defects, adhesions, mesh type, oral antibiotics, cardiac disease, diabetes, tobacco use, or seroma (X2 p>0.05). Those with a wound infection and/or abscess formation had a significantly higher recurrent hernia rate (60% vs. 8%, X2 p<0.001). Patients with pulmonary disease had a significantly higher recurrence rate (50% vs. 12%, X2 p=0.01). Conclusions: RS-VIHR with intraperitoneal mesh is a successful and less technically challenging method of repair than prior modifications. Aggressive efforts to identify infection and treat early may prevent abscess formation and subsequent recurrent hernia. Patients with chronic pulmonary disease have an unacceptably high recurrence rate and should not be considered as candidates for elective RS-VIHR.

KW - Prosthetic mesh

KW - Rives-Stoppa

KW - Ventral hernia repair

UR - http://www.scopus.com/inward/record.url?scp=20444481400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444481400&partnerID=8YFLogxK

U2 - 10.1007/s10029-005-0319-9

DO - 10.1007/s10029-005-0319-9

M3 - Article

C2 - 15723151

AN - SCOPUS:20444481400

VL - 9

SP - 162

EP - 166

JO - Hernia : the journal of hernias and abdominal wall surgery

JF - Hernia : the journal of hernias and abdominal wall surgery

SN - 1265-4906

IS - 2

ER -